Usman M. Bacha

发表

Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .

L. Amzel, E. Freire, S. Gabelli, 2010, Biochemistry.

Inhibition of HIV‐2 Protease by HIV‐1 Protease Inhibitors in Clinical Use

E. Freire, Evan T. Brower, Y. Kawasaki, 2008, Chemical biology & drug design.

Protease inhibition in African subtypes of HIV-1.

A. Velázquez‐Campoy, E. Freire, S. Vega, 2003, AIDS reviews.

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

A. Velázquez‐Campoy, E. Freire, S. Leavitt, 2004, Biochemistry.

Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro

E. Freire, S. Gabelli, Y. Kiso, 2008, Chemical biology & drug design.

Long-range cooperative interactions modulate dimerization in SARS 3CLpro.

E. Freire, Jennifer Barrila, Usman Bacha, 2006, Biochemistry.

Long Range Cooperative Interactions Modulate Dimerization in

E. Freire, Jennifer Barrila, Usman Bacha, 2008 .

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors

E. Freire, Y. Kiso, Y. Hayashi, 2009, Bioorganic & Medicinal Chemistry Letters.

Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors

E. Freire, Y. Kiso, Jennifer Barrila, 2006, Tetrahedron.